Bullfrog AI (BFRG) Competitors $1.82 +0.08 (+4.60%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFRG vs. BMEA, APLT, CABA, MDCX, ZIVO, VTGN, MIST, CTOR, ABOS, and SKYEShould you be buying Bullfrog AI stock or one of its competitors? The main competitors of Bullfrog AI include Biomea Fusion (BMEA), Applied Therapeutics (APLT), Cabaletta Bio (CABA), Medicus Pharma (MDCX), ZIVO Bioscience (ZIVO), Vistagen Therapeutics (VTGN), Milestone Pharmaceuticals (MIST), Citius Oncology (CTOR), Acumen Pharmaceuticals (ABOS), and Skye Bioscience (SKYE). These companies are all part of the "pharmaceutical products" industry. Bullfrog AI vs. Biomea Fusion Applied Therapeutics Cabaletta Bio Medicus Pharma ZIVO Bioscience Vistagen Therapeutics Milestone Pharmaceuticals Citius Oncology Acumen Pharmaceuticals Skye Bioscience Biomea Fusion (NASDAQ:BMEA) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, community ranking, risk, valuation, analyst recommendations, media sentiment and institutional ownership. Does the MarketBeat Community favor BMEA or BFRG? Biomea Fusion received 64 more outperform votes than Bullfrog AI when rated by MarketBeat users. CompanyUnderperformOutperformBiomea FusionOutperform Votes6469.57% Underperform Votes2830.43% Bullfrog AIN/AN/A Does the media prefer BMEA or BFRG? In the previous week, Biomea Fusion had 6 more articles in the media than Bullfrog AI. MarketBeat recorded 6 mentions for Biomea Fusion and 0 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 1.38 beat Biomea Fusion's score of 0.52 indicating that Bullfrog AI is being referred to more favorably in the news media. Company Overall Sentiment Biomea Fusion Positive Bullfrog AI Positive Which has more risk & volatility, BMEA or BFRG? Biomea Fusion has a beta of -0.07, meaning that its share price is 107% less volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Do analysts prefer BMEA or BFRG? Biomea Fusion presently has a consensus price target of $22.60, indicating a potential upside of 1,339.49%. Given Biomea Fusion's stronger consensus rating and higher possible upside, research analysts clearly believe Biomea Fusion is more favorable than Bullfrog AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biomea Fusion 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 3.08Bullfrog AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is BMEA or BFRG more profitable? Biomea Fusion's return on equity of -118.90% beat Bullfrog AI's return on equity.Company Net Margins Return on Equity Return on Assets Biomea FusionN/A -118.90% -93.66% Bullfrog AI N/A -141.39%-124.63% Do institutionals & insiders have more ownership in BMEA or BFRG? 96.7% of Biomea Fusion shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 27.6% of Biomea Fusion shares are held by insiders. Comparatively, 33.9% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better earnings and valuation, BMEA or BFRG? Bullfrog AI has higher revenue and earnings than Biomea Fusion. Bullfrog AI is trading at a lower price-to-earnings ratio than Biomea Fusion, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiomea FusionN/AN/A-$117.25M-$3.55-0.44Bullfrog AI$60K285.59-$5.36M-$0.81-2.25 SummaryBiomea Fusion beats Bullfrog AI on 10 of the 16 factors compared between the two stocks. Get Bullfrog AI News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRG vs. The Competition Export to ExcelMetricBullfrog AIPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.14M$6.55B$5.42B$8.48BDividend YieldN/A2.66%5.22%4.11%P/E Ratio-2.149.1426.8320.05Price / Sales285.59255.59393.86119.28Price / CashN/A65.8538.2534.62Price / Book4.236.546.874.61Net Income-$5.36M$143.51M$3.22B$248.19M7 Day Performance-5.21%4.66%5.65%2.88%1 Month Performance9.64%10.63%13.54%15.40%1 Year Performance-37.02%-1.05%18.16%7.68% Bullfrog AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRGBullfrog AI1.0203 of 5 stars$1.82+4.6%N/A-38.9%$17.14M$60,000.00-2.144Positive NewsEarnings ReportGap UpBMEABiomea Fusion2.7273 of 5 stars$1.77+8.6%$22.60+1,176.8%-87.7%$66.50MN/A-0.4450APLTApplied Therapeutics4.0988 of 5 stars$0.46+15.7%$6.10+1,218.6%-89.1%$65.49M$455,000.00-0.2930News CoverageAnalyst RevisionCABACabaletta Bio2.2924 of 5 stars$1.29+8.4%$21.00+1,527.9%-84.5%$65.46MN/A-0.6050News CoverageEarnings ReportUpcoming EarningsMDCXMedicus PharmaN/A$4.86+5.9%$23.50+383.5%N/A$65.27MN/A0.00N/AHigh Trading VolumeZIVOZIVO BioscienceN/A$16.97+6.3%N/AN/A$64.71M$15,850.00-3.4810Gap UpVTGNVistagen Therapeutics1.2402 of 5 stars$2.32+3.6%N/A-42.6%$64.65M$698,000.00-1.5740Positive NewsGap UpMISTMilestone Pharmaceuticals2.7248 of 5 stars$1.20+8.1%$17.00+1,316.7%-25.9%$64.16M$1M-1.4830Earnings ReportGap UpCTORCitius OncologyN/A$0.89+4.8%$3.00+235.9%N/A$63.90MN/A0.00N/AEarnings ReportABOSAcumen Pharmaceuticals2.6602 of 5 stars$1.05+7.1%$7.33+598.4%-70.7%$63.60MN/A-0.7620News CoverageEarnings ReportAnalyst RevisionSKYESkye Bioscience1.1525 of 5 stars$2.05+13.3%$16.60+709.8%-82.2%$63.50MN/A-2.5011News CoveragePositive NewsAnalyst ForecastGap Up Related Companies and Tools Related Companies Biomea Fusion Competitors Applied Therapeutics Competitors Cabaletta Bio Competitors Medicus Pharma Competitors ZIVO Bioscience Competitors Vistagen Therapeutics Competitors Milestone Pharmaceuticals Competitors Citius Oncology Competitors Acumen Pharmaceuticals Competitors Skye Bioscience Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRG) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bullfrog AI Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bullfrog AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
